Literature DB >> 14608117

The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines.

Rukiyah Van Dross1, Yue Xue, Alexandra Knudson, Jill C Pelling.   

Abstract

Apigenin is a nonmutagenic chemopreventive agent found in fruits and green vegetables. In this study, we used two different epithelial cell lines (308 mouse keratinocytes and HCT116 colon carcinoma cells) to determine the effect of apigenin on the mitogen-activated protein kinase (MAPK) cascade. Apigenin induced a dose-dependent phosphorylation of both extracellular signal-regulated protein kinase (ERK) and p38 kinase but had little effect on the phosphorylation of c-jun amino terminal kinase (JNK). We used immunoprecipitation-coupled kinase assays to show that apigenin increased the kinase activity of ERK and p38 but not JNK. Consistent with these results, we found that apigenin induced a 7.4-fold induction in the phosphorylation of Elk, the downstream phosphorylation target of ERK kinase. Similarly, apigenin induced a 3.2-fold induction in the phosphorylation of activating transcription factor-2, the downstream phosphorylation target of p38 kinase. Little change was observed in the phosphorylation of c-jun, the phosphorylation target of JNK. These data suggest that part of the chemopreventive activity of apigenin may be mediated by its ability to modulate the MAPK cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14608117     DOI: 10.1093/jn/133.11.3800S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  18 in total

Review 1.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

2.  Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53.

Authors:  Yi Zhong; Chutwadee Krisanapun; Seong-Ho Lee; Thararat Nualsanit; Carl Sams; Penchom Peungvicha; Seung Joon Baek
Journal:  Eur J Cancer       Date:  2010-08-13       Impact factor: 9.162

3.  Apigenin Decreases Acinar Cell Damage in Pancreatitis.

Authors:  Amy A Mrazek; Vandanajay Bhatia; Miriam Falzon; Heidi Spratt; Celia Chao; Mark R Hellmich
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

Review 4.  Apigenin: a promising molecule for cancer prevention.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

5.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

6.  Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells.

Authors:  Hung Pham; Monica Chen; Hiroki Takahashi; Jonathan King; Howard A Reber; Oscar Joe Hines; Stephen Pandol; Guido Eibl
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

7.  Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair.

Authors:  Daniel Arango; Arti Parihar; Frederick A Villamena; Liwen Wang; Michael A Freitas; Erich Grotewold; Andrea I Doseff
Journal:  Biochem Pharmacol       Date:  2012-09-14       Impact factor: 5.858

8.  Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells.

Authors:  A R Hussain; A S Khan; S O Ahmed; M Ahmed; L C Platanias; K S Al-Kuraya; S Uddin
Journal:  Cell Prolif       Date:  2010-01-14       Impact factor: 6.831

Review 9.  Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?

Authors:  Eva F DeRango-Adem; Jonathan Blay
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

10.  Time course changes of anti- and pro-apoptotic proteins in apigenin-induced genotoxicity.

Authors:  Fotini Papachristou; Ekaterini Chatzaki; Athanasios Petrou; Ioanna Kougioumtzi; Nikolaos Katsikogiannis; Alexandros Papalambros; Grigorios Tripsianis; Constantinos Simopoulos; Alexandra K Tsaroucha
Journal:  Chin Med       Date:  2013-05-04       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.